This interview discusses a new preprint study led by Dr. Rob Wüst, which investigates the role of deconditioning in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid. The research compared physiological changes in healthy individuals undergoing 60 days of bed rest (mimicking deconditioning) with those observed in ME/CFS and Long Covid patients during exercise tests and muscle biopsies. While both deconditioned healthy individuals and patient groups showed similar overall reductions in exercise capacity, deeper analysis revealed significant underlying physiological differences. Critically, the expected correlation between exercise capacity and skeletal muscle health markers (like capillaries and mitochondria), which was preserved in bed-rested healthy individuals, was absent in ME/CFS and Long Covid patients. This finding strongly suggests that the disabling symptoms and muscle abnormalities in ME/CFS and Long Covid are not solely due to deconditioning, implying the involvement of additional, more complex, disease-specific factors such as microvascular dysfunction, autoimmunity, neurological changes, or ion channel abnormalities, thereby challenging the long-standing deconditioning hypothesis.
Exploring the Deconditioning Hypothesis in ME/CFS and Long Covid
0:02 Introduction: Dr. Rob Wüst introduces his group's new preprint study comparing the effects of bed rest (deconditioning) in healthy individuals with the exercise responses and muscle issues observed in ME/CFS and Long Covid patients.
0:37 Bed Rest Research Context: The study leverages previous research on inactivity and deconditioning conducted in collaboration with space agencies like NASA and ESA, using bed rest as an analogue for microgravity to understand physical deconditioning.
2:12 Documented Effects of 60-Day Bed Rest: Prior studies showed that 60 days of bed rest lead to initial signs of type 2 diabetes (insulin resistance), loss of muscle and mitochondrial mass, and accumulation of sugars and fats, resulting in smaller, more insulin-resistant muscles.
3:35 Challenging the Deconditioning Argument: The new research directly challenges the prevailing hypothesis that ME/CFS and Long Covid symptoms are primarily caused by deconditioning, a theory that historically underpinned therapies like Graded Exercise Therapy (GET) and Cognitive Behavioral Therapy (CBT).
5:46 Patient Cohorts: The study included healthy controls, Long Covid patients (ill for 1-3 years), and ME/CFS patients diagnosed before the COVID-19 pandemic (ill for at least 5 years), allowing for investigation of potential disease duration effects.
9:50 Distinguishing Physiological Responses: While overall exercise capacity appeared superficially similar between bed-rested healthy individuals and patient groups, a deeper examination of cardiopulmonary function and skeletal muscle changes (e.g., muscle size, capillaries, mitochondria) revealed distinct differences between them.
12:54 Loss of Muscle-Exercise Correlation in Patients: In healthy individuals (even after bed rest), a clear correlation exists between exercise capacity and markers of skeletal muscle health. This crucial physiological link was absent in ME/CFS and Long Covid patients, indicating that their muscle and exercise impairments are not simply a result of inactivity.
15:55 Deconditioning is Not the Sole Cause: The study concludes that while deconditioning might occur in these patient populations, the observed physiological differences are not solely due to deconditioning, implying an "additional factor" is at play.
17:01 Focus on Physical Post-Exertional Malaise (PEM): The study specifically focused on physical PEM, as it directly relates to muscle biopsies and exercise testing, acknowledging that cognitive PEM is a separate area requiring different research approaches.
20:41 Broader Implications and Future Research: The findings necessitate a shift away from deconditioning as the primary explanation for ME/CFS and Long Covid. Dr. Wüst emphasizes the need to explore other contributing factors ("pillars") such as microvascular dysfunction, autoimmunity, neurological changes, and ion channel abnormalities, which are likely direct disease mediators. The study is currently a preprint awaiting peer review.